Nokhova et al., 2026 - Google Patents
Anelloviruses: From General Biology to Their Role as Biomarkers of Immune Competence in HIV InfectionNokhova et al., 2026
View HTML- Document ID
- 952633814664852118
- Author
- Nokhova A
- Elfimov K
- Shestopalov A
- Gashnikova N
- Kurskaya O
- Publication year
- Publication venue
- Viruses
External Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chung et al. | Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies | |
| Peretti et al. | Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution | |
| Isaacs et al. | Viruses and type 1 diabetes: from enteroviruses to the virome | |
| Ljubin-Sternak et al. | Rhinovirus—A true respiratory threat or a common inconvenience of childhood? | |
| Dodi et al. | Virome in the lungs: the role of anelloviruses in childhood respiratory diseases | |
| Prakash et al. | Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update | |
| Oliveira Neto et al. | The emergence of saliva as a diagnostic and prognostic tool for viral infections | |
| Eberhardt et al. | Evaluation of a new spike (S)-protein-based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG | |
| James et al. | Comparison of serological assays for the detection of SARS-CoV-2 antibodies | |
| Pavulraj et al. | Fatal elephant endotheliotropic herpesvirus infection of two young Asian elephants | |
| Grudlewska-Buda et al. | Sars-cov-2—morphology, transmission and diagnosis during pandemic, review with element of meta-analysis | |
| Faist et al. | Virus infection and systemic inflammation: lessons learnt from COVID-19 and beyond | |
| Truong et al. | A cell-adapted live-attenuated vaccine candidate protects pigs against the homologous strain VNUA-ASFV-05L1, a representative strain of the contemporary pandemic African swine fever virus | |
| Brani et al. | Torque teno virus: lights and shades | |
| Anastasiou et al. | Comprehensive evaluation of hepatitis E serology and molecular testing in a large cohort | |
| Pavia et al. | Does the human gut virome contribute to host health or disease? | |
| Harfoot et al. | Characterization of the first SARS-CoV-2 isolates from aotearoa New Zealand as part of a rapid response to the COVID-19 pandemic | |
| Prezioso et al. | Structural analysis of merkel cell polyomavirus (MCPyV) viral capsid protein 1 (VP1) in HIV-1 infected individuals | |
| Chan et al. | Targeted profiling of immunological genes during norovirus replication in human intestinal enteroids | |
| Tung et al. | Low risk of occult hepatitis B infection among Vietnamese blood donors | |
| Moreni et al. | Non-polio enterovirus C replicate in both airway and intestine organotypic cultures | |
| Mezzetti et al. | Autoimmune heart disease: a comprehensive summary for forensic practice | |
| Venturini et al. | Cytomegalovirus Genetic Diversity and Evolution: Insights into Genotypes and Their Role in Viral Pathogenesis | |
| Kiś et al. | Can the Epstein–Barr Virus Play a Role in the Development of Prostate Cancer? | |
| Jeles et al. | Seroprevalence of four polyomaviruses linked to dermatological diseases: new findings and a comprehensive analysis |